Your browser doesn't support javascript.
loading
Development and evaluation of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)-study protocol for a randomised controlled trial.
Rahn, Anne Christin; Wenzel, Lisa; Icks, Andrea; Stahmann, Alexander; Scheiderbauer, Jutta; Grentzenberg, Kristina; Vomhof, Markus; Montalbo, Joseph; Friede, Tim; Heesen, Christoph; Köpke, Sascha.
Afiliação
  • Rahn AC; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. anne.christin.rahn@uni-oldenburg.de.
  • Wenzel L; Department of Health Services Research, Carl von Ossietzky University Oldenburg, Oldenburg, Germany. anne.christin.rahn@uni-oldenburg.de.
  • Icks A; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Stahmann A; Institute of Nursing Science, University Hospital Cologne and Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Scheiderbauer J; Institute for Health Services Research and Health Economics, Centre for Health and Society, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Grentzenberg K; MS Forschungs- und Projektentwicklungs-gGmbH, Hannover, Germany.
  • Vomhof M; Stiftung für Selbstbestimmung und Selbstvertretung von MS-Betroffenen, Trier, Germany.
  • Montalbo J; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Friede T; Institute for Health Services Research and Health Economics, Centre for Health and Society, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Heesen C; Institute for Health Services Research and Health Economics, Centre for Health and Society, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Köpke S; Department of Medical Statistics, University Medical, Göttingen, Germany.
Trials ; 22(1): 139, 2021 Feb 14.
Article em En | MEDLINE | ID: mdl-33583424

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Esclerose Múltipla Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Trials Assunto da revista: MEDICINA / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido